TITANBIO - Titan Bio-Tech Ltd. Share Price

Chemicals & Petrochemicals

Sharesguru Stock Score

TITANBIO

39/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹400.15+12.75(+3.29%)

Market Open as of Mar 24, 2026, 15:30 IST

Select time range

Pros

Momentum: Stock price has a strong positive momentum. Stock is up 30.5% in last 30 days.

Past Returns: Outperforming stock! In past three years, the stock has provided 111.5% return compared to 9.9% by NIFTY 50.

Growth: Good revenue growth. With 38.9% growth over past three years, the company is going strong.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Profitability: Recent profitability of 14% is a good sign.

Balance Sheet: Strong Balance Sheet.

Cons

Size: It is a small market cap company and can be volatile.

Valuation
Market Cap	874.05 Cr
Price/Earnings (Trailing)	58.84
Price/Sales (Trailing)	4.87
EV/EBITDA	27.09
Price/Free Cashflow	99.32
MarketCap/EBT	31.83
Enterprise Value	880.51 Cr

Fundamentals
Revenue (TTM)	197.21 Cr
Rev. Growth (Yr)	44.9%
Earnings (TTM)	27.2 Cr
Earnings Growth (Yr)	94.3%

Profitability
Operating Margin	17%
EBT Margin	17%
Return on Equity	16.35%
Return on Assets	13.43%
Free Cashflow Yield	1.01%

Growth & Returns
Price Change 1W	11%
Price Change 1M	30.5%
Price Change 6M	99.6%
Price Change 1Y	311.2%
3Y Cumulative Return	111.5%
5Y Cumulative Return	61.2%
7Y Cumulative Return	70.7%
10Y Cumulative Return	48.6%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-9.87 Cr
Cash Flow from Operations (TTM)	20.12 Cr
Cash Flow from Financing (TTM)	-7.96 Cr
Cash & Equivalents	1.63 Cr
Free Cash Flow (TTM)	10.73 Cr
Free Cash Flow/Share (TTM)	12.99

Balance Sheet
Total Assets	202.49 Cr
Total Liabilities	36.07 Cr
Shareholder Equity	166.41 Cr
Current Assets	89.84 Cr
Current Liabilities	32.29 Cr
Net PPE	47.54 Cr
Inventory	45.62 Cr
Goodwill	0.00

Capital Structure & Leverage
Debt Ratio	0.04
Debt/Equity	0.05
Interest Coverage	42.58
Interest/Cashflow Ops	28.51

Dividend & Shareholder Returns
Dividend/Share (TTM)	0.4
Dividend Yield	0.10%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Technical Indicators
RSI (14d)	76.12
RSI (5d)	85.37
RSI (21d)	67.25
MACD Signal	Buy
Stochastic Oscillator Signal	Sell
SharesGuru Signal	Buy
RSI Signal	Sell
RSI5 Signal	Sell
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Shareholder Name	Holding %
Titan Securities Ltd	33.59%
Tanita Leasing & Finance Limited	9.49%
Connoisseur Management Services Private Limit	6.78%
Manish Goel	1.74%
Suresh Chand Singla	1.28%
Manju Singla	0.86%
Madhu Gupta	0.8%
Raja Singla	0.74%
Supriya Singla	0.66%
Udit Singla	0.61%
Shivom Singla	0.43%
Naresh Kumar Singla	0.42%
Naresh Kumar Singla Huf	0.12%
Ravinder Gupta	0.1%
Ravinder Gupta Huf	0%

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	-4.9%	156	164	144	153	142	79
Other Income	288%	3.91	1.75	1.94	1.02	0.79	0.45
Total Income	-3.6%	160	166	146	154	143	80
Cost of Materials	-7.5%	75	81	71	75	67	40
Employee Expense	8.7%	26	24	18	16	14	12
Finance costs	-217.6%	0.8	1.17	0.75	1.28	1.67	2.34
Depreciation and Amortization	36.1%	4.17	3.33	2.6	2.54	2.22	1.8
Other expenses	6.9%	32	30	26	21	17	14
Total Expenses	1.5%	136	134	118	116	100	70
Profit Before exceptional items and Tax	-25.8%	24	32	28	38	43	9.79
Exceptional items before tax	-	0	0	0	0	-0.32	0.61
Total profit before tax	-25.8%	24	32	28	38	43	10
Current tax	-26.8%	5.97	7.79	7.21	9.7	11	2.39
Deferred tax	5.4%	0.13	0.08	-0.12	-0.06	0.14	0.17
Total tax	-25.8%	6.1	7.87	7.09	9.65	11	2.57
Total profit (loss) for period	-12.5%	22	25	25	29	32	7.84
Other comp. income net of taxes	-12%	0.07	0.17	0	0	0.05	-0.05
Total Comprehensive Income	-12.5%	22	25	25	29	32	7.79
Earnings Per Share, Basic	-10.9%	5.212	5.728	6.012	6.1312	7.342	1.71
Earnings Per Share, Diluted	-10.9%	5.212	5.728	6.012	6.1312	7.342	1.71

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Jun-2024
Revenue From Operations	5.7%	57	54	46	35	38	43
Other Income	-18.8%	1.26	1.32	0.72	1.38	1.59	0.62
Total Income	3.6%	58	56	47	37	40	44
Cost of Materials	0%	27	27	19	17	20	22
Employee Expense	18%	8.53	7.38	7.01	6.94	6.67	6.27
Finance costs	5.1%	0.26	0.22	0.2	0.08	0.15	0.31
Depreciation and Amortization	28.6%	1.27	1.21	1.15	0.84	1.18	1.05
Other expenses	-20.2%	9.78	12	6.8	8.64	8.43	6.83
Total Expenses	2.2%	47	46	39	32	35	36
Profit Before exceptional items and Tax	21.7%	11	9.22	8.11	5.03	5.1	7.52
Total profit before tax	21.7%	11	9.22	8.11	5.03	5.1	7.52
Current tax	-12.4%	2.63	2.86	1.92	1.25	1.28	1.82
Deferred tax	38%	0.07	-0.5	0.03	0.02	0.03	0
Total tax	24.3%	2.69	2.36	1.95	1.26	1.3	1.82
Total profit (loss) for period	11.4%	8.53	7.76	6.86	4.05	4.39	6.4
Other comp. income net of taxes	0%	0.02	0.02	0.02	-0.06	0.04	0.04
Total Comprehensive Income	11.4%	8.55	7.78	6.88	3.99	4.43	6.44
Earnings Per Share, Basic	20.9%	2.064	1.88	1.66	0.98	1.062	1.548
Earnings Per Share, Diluted	20.9%	2.064	1.88	1.66	0.98	1.062	1.548

Description	(%) Q/Q	Sep-2025	Mar-2025	Mar-2024	Sep-2023	Mar-2023	Sep-2022
Cash and cash equivalents	-84.7%	1.63	5.13	2.84	4.56	4.86	3.47
Total current financial assets	87%	44	24	22	28	26	29
Inventories	-10%	46	51	46	42	36	40
Current tax assets	-	-	0.07	0.05	-	0	-
Total current assets	14.1%	90	79	72	75	68	70
Property, plant and equipment	-16.1%	48	57	52	44	36	35
Capital work-in-progress	269.1%	3.51	1.68	2.53	9.45	13	7.01
Investment property	-	8.95	0	0	0	-	-
Goodwill	-	0	0	0	0.07	0	0
Non-current investments	46.9%	48	33	28	17	15	9.74
Total non-current financial assets	44.4%	53	37	30	19	17	11
Total non-current assets	17.9%	113	96	84	73	66	53
Total assets	15.5%	202	175	157	148	135	124
Borrowings, non-current	8.5%	0.25	0.18	0.45	1.18	0.3	1.61
Total non-current financial liabilities	-29.3%	0.25	0.42	1.15	2.28	1.43	2.7
Provisions, non-current	23.8%	1.78	1.63	1.48	1.75	1.62	1.54
Total non-current liabilities	8.2%	3.78	3.57	4	5.28	4.25	5.49
Borrowings, current	643.5%	7.84	1.92	6.72	6.06	6.7	4.47
Total current financial liabilities	76.9%	24	14	16	16	18	13
Provisions, current	0%	0.63	0.63	0.56	0.33	0.33	0.31
Current tax liabilities	-	1.85	-	0	0.77	0.03	1.07
Total current liabilities	82.4%	32	18	19	21	20	17
Total liabilities	75%	36	21	23	27	25	22
Equity share capital	0%	8.26	8.26	8.26	8.26	8.26	8.26
Non controlling interest	-	-	0	-	-	0	-
Total equity	8.6%	166	153	133	121	110	102
Total equity and liabilities	15.5%	202	175	157	148	135	124

Category	TITANBIO	Chemicals
PE	59.02	39.91
PS	4.87	3.70
Growth	15.7 %	7.2 %

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-217.6%	0.8	1.17	0.75	1.28	-	-
Change in inventories	40.9%	-5.15	-9.4	-1.49	-9.76	-	-
Depreciation	36.1%	4.17	3.33	2.6	2.54	-	-
Net Cashflows from Operations	-10.7%	26	29	29	31	-	-
Income taxes paid (refund)	-27%	5.99	7.84	7.47	8.82	-	-
Other inflows (outflows) of cash	-	0	0	0	0.28	-	-
Net Cashflows From Operating Activities	-5%	20	21	21	23	-	-
Cashflows used in obtaining control of subsidiaries	-97.1%	1.32	12	7.56	0	-	-
Purchase of property, plant and equipment	8.8%	9.39	8.71	13	19	-	-
Proceeds from sales of investment property	-	0.02	0	0	0	-	-
Purchase of intangible assets	-	0.05	0	0	0	-	-
Purchase of intangible assets under development	-	-0.01	0	0	0	-	-
Purchase of other long-term assets	-	-0.85	0	0	0	-	-
Interest received	-	0.01	0	0	0	-	-
Net Cashflows From Investing Activities	49%	-9.87	-20.3	-20.73	-18.78	-	-
Proceeds from changes in ownership interests in subsidiaries	-	0	0	0	5.64	-	-
Repayments of borrowings	447.9%	5.07	-0.17	0.53	-2.73	-	-
Payments of lease liabilities	-	0.44	0	-0.11	-0.23	-	-
Dividends paid	32.7%	1.65	1.49	1.24	1.24	-	-
Interest paid	-217.6%	0.8	1.17	0.75	1.28	-	-
Net Cashflows from Financing Activities	-131.5%	-7.96	-2.87	-2.4	6.08	-	-
Net change in cash and cash eq.	142.7%	2.29	-2.02	-1.95	10	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	-217.6%	0.8	1.17	0.75	0.78	-	-
Change in inventories	40.9%	-5.15	-9.4	-1.49	-7.85	-	-
Depreciation	36.1%	4.17	3.33	2.6	2.37	-	-
Net Cashflows from Operations	-10.7%	26	29	29	29	-	-
Income taxes paid (refund)	-27%	5.99	7.84	7.47	7.12	-	-
Net Cashflows From Operating Activities	-5%	20	21	21	22	-	-
Cashflows used in obtaining control of subsidiaries	-97.1%	1.32	12	7.56	0	-	-
Purchase of property, plant and equipment	8.8%	9.39	8.71	13	14	-	-
Proceeds from sales of investment property	-	0.02	0	0	0	-	-
Purchase of intangible assets	-	0.05	0	0	0	-	-
Purchase of intangible assets under development	-	-0.01	0	0	0	-	-
Purchase of other long-term assets	-	-0.85	0	0	0	-	-
Interest received	-	0.01	0	0	0	-	-
Net Cashflows From Investing Activities	49%	-9.87	-20.3	-20.73	-16.44	-	-
Proceeds from borrowings	-	0	0	0	-0.99	-	-
Repayments of borrowings	447.9%	5.07	-0.17	0.53	0.75	-	-
Payments of lease liabilities	-	0.44	0	-0.11	0.25	-	-
Dividends paid	32.7%	1.65	1.49	1.24	1.24	-	-
Interest paid	-217.6%	0.8	1.17	0.75	0.78	-	-
Net Cashflows from Financing Activities	-131.5%	-7.96	-2.87	-2.4	-4.01	-	-
Net change in cash and cash eq.	142.7%	2.29	-2.02	-1.95	1.51	-	-

Category	TITANBIO	Chemicals
PE	59.02	39.91
PS	4.87	3.70
Growth	15.7 %	7.2 %

TITANBIO - Titan Bio-Tech Ltd. Share Price

TITANBIO

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

TITANBIO

TITANBIO - Titan Bio-Tech Ltd. Share Price

TITANBIO

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

TITANBIO

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Important Disclosure & Data Context